Pulmonary hypertension in sickle cell disease: Diagnosis and management

Kenneth I. Ataga, Elizabeth S. Klings

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The increased survival of patients with sickle cell disease (SCD) into adulthood is associated with an increased incidence of multiorgan dysfunction and a progressive systemic and pulmonary vasculopathy. The high prevalence of an elevated tricuspid regurgitant jet velocity and its association with an increased risk of death in adult patients is well established. However, there has been controversy regarding the prevalence of pulmonary hypertension (PH) and its association with mortality in SCD. Multiple recently published reports demonstrate that PH as diagnosed by right heart catheterization is common in adult SCD patients, with a prevalence of 6%-11%. Furthermore, PH is associated with an increased risk of death in SCD patients. In this chapter, we provide evidence for the high prevalence of PH in SCD and its association with mortality and make recommendations for its evaluation and management. Finally, we provide the rationale for screening for this life-threatening complication in adult patients with SCD.

Original languageEnglish (US)
Pages (from-to)425-431
Number of pages7
JournalHematology
Volume2014
Issue number1
DOIs
StatePublished - Dec 5 2014

Fingerprint

Sickle Cell Anemia
Disease Management
Pulmonary Hypertension
Mortality
Cardiac Catheterization
Lung
Survival
Incidence

All Science Journal Classification (ASJC) codes

  • Hematology
  • Medicine(all)

Cite this

Pulmonary hypertension in sickle cell disease : Diagnosis and management. / Ataga, Kenneth I.; Klings, Elizabeth S.

In: Hematology, Vol. 2014, No. 1, 05.12.2014, p. 425-431.

Research output: Contribution to journalArticle

Ataga, Kenneth I. ; Klings, Elizabeth S. / Pulmonary hypertension in sickle cell disease : Diagnosis and management. In: Hematology. 2014 ; Vol. 2014, No. 1. pp. 425-431.
@article{652743ed94f948408d888fe16d7f4865,
title = "Pulmonary hypertension in sickle cell disease: Diagnosis and management",
abstract = "The increased survival of patients with sickle cell disease (SCD) into adulthood is associated with an increased incidence of multiorgan dysfunction and a progressive systemic and pulmonary vasculopathy. The high prevalence of an elevated tricuspid regurgitant jet velocity and its association with an increased risk of death in adult patients is well established. However, there has been controversy regarding the prevalence of pulmonary hypertension (PH) and its association with mortality in SCD. Multiple recently published reports demonstrate that PH as diagnosed by right heart catheterization is common in adult SCD patients, with a prevalence of 6{\%}-11{\%}. Furthermore, PH is associated with an increased risk of death in SCD patients. In this chapter, we provide evidence for the high prevalence of PH in SCD and its association with mortality and make recommendations for its evaluation and management. Finally, we provide the rationale for screening for this life-threatening complication in adult patients with SCD.",
author = "Ataga, {Kenneth I.} and Klings, {Elizabeth S.}",
year = "2014",
month = "12",
day = "5",
doi = "10.1182/asheducation-2014.1.425",
language = "English (US)",
volume = "2014",
pages = "425--431",
journal = "Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program",
issn = "1520-4391",
publisher = "American Society of Hematology",
number = "1",

}

TY - JOUR

T1 - Pulmonary hypertension in sickle cell disease

T2 - Diagnosis and management

AU - Ataga, Kenneth I.

AU - Klings, Elizabeth S.

PY - 2014/12/5

Y1 - 2014/12/5

N2 - The increased survival of patients with sickle cell disease (SCD) into adulthood is associated with an increased incidence of multiorgan dysfunction and a progressive systemic and pulmonary vasculopathy. The high prevalence of an elevated tricuspid regurgitant jet velocity and its association with an increased risk of death in adult patients is well established. However, there has been controversy regarding the prevalence of pulmonary hypertension (PH) and its association with mortality in SCD. Multiple recently published reports demonstrate that PH as diagnosed by right heart catheterization is common in adult SCD patients, with a prevalence of 6%-11%. Furthermore, PH is associated with an increased risk of death in SCD patients. In this chapter, we provide evidence for the high prevalence of PH in SCD and its association with mortality and make recommendations for its evaluation and management. Finally, we provide the rationale for screening for this life-threatening complication in adult patients with SCD.

AB - The increased survival of patients with sickle cell disease (SCD) into adulthood is associated with an increased incidence of multiorgan dysfunction and a progressive systemic and pulmonary vasculopathy. The high prevalence of an elevated tricuspid regurgitant jet velocity and its association with an increased risk of death in adult patients is well established. However, there has been controversy regarding the prevalence of pulmonary hypertension (PH) and its association with mortality in SCD. Multiple recently published reports demonstrate that PH as diagnosed by right heart catheterization is common in adult SCD patients, with a prevalence of 6%-11%. Furthermore, PH is associated with an increased risk of death in SCD patients. In this chapter, we provide evidence for the high prevalence of PH in SCD and its association with mortality and make recommendations for its evaluation and management. Finally, we provide the rationale for screening for this life-threatening complication in adult patients with SCD.

UR - http://www.scopus.com/inward/record.url?scp=84937541114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937541114&partnerID=8YFLogxK

U2 - 10.1182/asheducation-2014.1.425

DO - 10.1182/asheducation-2014.1.425

M3 - Article

C2 - 25696889

AN - SCOPUS:84937541114

VL - 2014

SP - 425

EP - 431

JO - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

JF - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

SN - 1520-4391

IS - 1

ER -